The store will not work correctly when cookies are disabled.
6-Bromo-3-(3-fluorostyryl)-2-methylquinazolin-4(3H)-one
ID: ALA5287417
Max Phase: Preclinical
Molecular Formula: C17H12BrFN2O
Molecular Weight: 359.20
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccc(Br)cc2c(=O)n1/C=C/c1cccc(F)c1
Standard InChI: InChI=1S/C17H12BrFN2O/c1-11-20-16-6-5-13(18)10-15(16)17(22)21(11)8-7-12-3-2-4-14(19)9-12/h2-10H,1H3/b8-7+
Standard InChI Key: XTQPONKFXAPBGE-BQYQJAHWSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-3.5702 -0.2041 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-2.8557 -0.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8557 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1395 -1.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4296 -1.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7120 -1.8552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -1.4387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7139 -1.8511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -0.6178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7121 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4265 -0.6178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1410 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8586 -0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5702 -0.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5702 0.6176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8539 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1410 0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8539 1.8552 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.7171 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7171 0.6195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4296 -0.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1413 -0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
16 18 1 0
9 19 1 0
19 20 2 0
21 19 1 0
5 21 2 0
21 22 1 0
22 2 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.20 | Molecular Weight (Monoisotopic): 358.0117 | AlogP: 4.23 | #Rotatable Bonds: 2 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.67 | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -1.09 |
References
1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |